Management of Drug Resistance in Mantle Cell Lymphoma

por Roué, Gaël, Sola, Brigitte
Publicado 2020

BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma

por Esteve-Arenys, Anna, Roue, Gael
Publicado 2018

Ikaros as a downstream mediator of BCR blockade therapy in B-cell non-Hodgkin lymphoma

por Ribeiro, Marcelo Lima, Normant, Emmanuel, Roué, Gaël
Publicado 2022

Pharmacological Targeting of BET Bromodomain Proteins in Acute Myeloid Leukemia and Malignant Lymphomas: From Molecular Characterization to Clinical Applications

por Reyes-Garau, Diana, Ribeiro, Marcelo L., Roué, Gaël
Publicado 2019

Epigenetic targets in B- and T-cell lymphomas: latest developments

por Ribeiro, Marcelo Lima, Sánchez Vinces, Salvador, Mondragon, Laura, Roué, Gael
Publicado 2023

Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma

por Santos, Juliana Carvalho, Profitós-Pelejà, Núria, Ribeiro, Marcelo Lima, Roué, Gaël
Publicado 2022

RHOA Therapeutic Targeting in Hematological Cancers

por Santos, Juliana Carvalho, Profitós-Pelejà, Núria, Sánchez-Vinces, Salvador, Roué, Gaël
Publicado 2023

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas

por Witte, Hanno Maximilian, Künstner, Axel, Chteinberg, Emil, Piazza, Francesco, Roué, Gaël, Gebauer, Niklas
Publicado 2023

Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma

por Ribeiro, Marcelo L., Reyes-Garau, Diana, Armengol, Marc, Fernández-Serrano, Miranda, Roué, Gaël
Publicado 2019

AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation

por Maliandi, Maria Victoria, Mato-Berciano, Ana, Sobrevals, Luciano, Roué, Gaël, José, Anabel, Fillat, Cristina
Publicado 2015

Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas

por Profitós-Pelejà, Núria, Santos, Juliana Carvalho, Marín-Niebla, Ana, Roué, Gaël, Ribeiro, Marcelo Lima
Publicado 2022

Immune-Checkpoint Inhibitors in B-Cell Lymphoma

por Armengol, Marc, Santos, Juliana Carvalho, Fernández-Serrano, Miranda, Profitós-Pelejà, Núria, Ribeiro, Marcelo Lima, Roué, Gaël
Publicado 2021

Histone Modifications and Their Targeting in Lymphoid Malignancies

por Fernández-Serrano, Miranda, Winkler, René, Santos, Juliana C., Le Pannérer, Marguerite-Marie, Buschbeck, Marcus, Roué, Gaël
Publicado 2021

Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing

por Pontel, Lucas B., Bueno-Costa, Alberto, Morellato, Agustín E., Carvalho Santos, Juliana, Roué, Gaël, Esteller, Manel
Publicado 2022

Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-c...

por Dlouhy, Ivan, Armengol, Marc, Recasens-Zorzo, Clara, Ribeiro, Marcelo L., Pérez-Galán, Patricia, Bosch, Francesc, López-Guillermo, Armando, Roué, Gaël
Publicado 2021

Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-c...

por Dlouhy, Ivan, Armengol, Marc, Recasens-Zorzo, Clara, Ribeiro, Marcelo L, Pérez-Galán, Patricia, Bosch, Francesc, López-Guillermo, Armando, Roué, Gaël
Publicado 2022

Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma

por Rosich, Laia, Montraveta, Arnau, Xargay-Torrent, Sílvia, López-Guerra, Mónica, Roldán, Jocabed, Aymerich, Marta, Salaverria, Itziar, Beà, Sílvia, Campo, Elías, Pérez-Galán, Patricia, Roué, Gaël, Colomer, Dolors
Publicado 2014

Bcl-2(high) mantle cell lymphoma cells are sensitized to acadesine with ABT-199

por Montraveta, Arnau, Xargay-Torrent, Sílvia, Rosich, Laia, López-Guerra, Mònica, Roldán, Jocabed, Rodríguez, Vanina, Lee-Vergés, Eriong, de Frías, Mercè, Campàs, Clara, Campo, Elias, Roué, Gaël, Colomer, Dolors
Publicado 2015

The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling

por Díaz, Tania, Rodríguez, Vanina, Lozano, Ester, Mena, Mari-Pau, Calderón, Marcos, Rosiñol, Laura, Martínez, Antonio, Tovar, Natalia, Pérez-Galán, Patricia, Bladé, Joan, Roué, Gaël, de Larrea, Carlos Fernández
Publicado 2017

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma

por Montraveta, Arnau, Xargay-Torrent, Sílvia, López-Guerra, Mónica, Rosich, Laia, Pérez-Galán, Patricia, Salaverria, Itziar, Beà, Silvia, Kalko, Susana G., de Frias, Mercè, Campàs, Clara, Roué, Gaël, Colomer, Dolors
Publicado 2014